Filing Flows › Selectis Health (GBCS) › Q2 2025
Selectis Health (GBCS) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 14, 2025
Selectis Health (GBCS) reported revenue of $10.4M for the second quarter 2025 (Q2 2025), +9% from a year earlier and -0.4% from the quarter before. Operating margin was -4.3%, net loss $308K (3.0% of revenue).
Selectis Health, Q2 2025: revenue $10.4M (+9% year over year), operating margin -4.3%, net loss $308K, operating cash flow −$77K. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.4M | -0.4% | +9% |
| Operating profit | −$450K | — | — |
| Net earnings | −$308K | — | — |
| Operating cash flow | −$77K | -107% | — |
What changed
Revenue was $10.4M in Q2 2025, up 9% year over year and roughly flat from the previous quarter.
Operating costs exceeded revenue by $450K, an operating margin of -4.3%. Total costs grew 5% against revenue growth of 9%. The quarter ended with a net loss of $308K, narrower than the previous quarter's $656K loss. Non-operating items added $142K, -46% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$77K. Non-cash charges added back $363K of depreciation. Working capital and other items used $132K. Capital expenditures of $164K exceeded it, leaving free cash flow of −$241K.
Questions
What was Selectis Health's revenue in the second quarter 2025?
Selectis Health (GBCS) reported revenue of $10.4M for the second quarter 2025 (Q2 2025), +9% from a year earlier and -0.4% from the quarter before.
Was Selectis Health profitable in the second quarter 2025?
Operating loss was $450K (-4.3% of revenue) and net loss $308K.
Source: Selectis Health 10-Q on SEC EDGAR.